Synthesis, Computational Pharmacokinetics Report, Conceptual DFT-Based Calculations and Anti-Acetylcholinesterase Activity of Hydroxyapatite Nanoparticles Derived From
Alzheimer’s disease
Conceptual DFT
amyloid plaques
computational pharmacokinetics
molecular docking
neurofibrillary tangles
neuropathology
Journal
Frontiers in chemistry
ISSN: 2296-2646
Titre abrégé: Front Chem
Pays: Switzerland
ID NLM: 101627988
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
07
2021
accepted:
17
09
2021
entrez:
25
10
2021
pubmed:
26
10
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Over the years, Alzheimer's disease (AD) treatments have been a major focus, culminating in the identification of promising therapeutic targets. A herbal therapy approach has been required by the demand of AD stage-dependent optimal settings. Present study describes the evaluation of anti-acetylcholinesterase (AChE) activity of hydroxyapatite nanoparticles derived from an
Identifiants
pubmed: 34692640
doi: 10.3389/fchem.2021.741037
pii: 741037
pmc: PMC8529163
doi:
Types de publication
Journal Article
Langues
eng
Pagination
741037Informations de copyright
Copyright © 2021 Pradeep, Jain, Dharmashekara, Prasad, Akshatha, Pruthvish, Amachawadi, Srinivasa, Syed, Elgorban, Al Kheraif, Ortega-Castro, Frau, Flores-Holguín, Shivamallu, Kollur and Glossman-Mitnik.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Biomolecules. 2021 Mar 05;11(3):
pubmed: 33807771
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Apr 15;107:196-202
pubmed: 23419788
J Med Chem. 2015 May 14;58(9):4066-72
pubmed: 25860834
Brain Pathol. 1991 Jul;1(4):279-86
pubmed: 1669718
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):198-210
pubmed: 15615638
Lancet. 2006 Jul 29;368(9533):387-403
pubmed: 16876668
Expert Rev Neurother. 2011 May;11(5):677-708
pubmed: 21539488
Saudi J Biol Sci. 2021 Jan;28(1):1040-1051
pubmed: 33424398
JAMA. 1999 Apr 21;281(15):1433-4
pubmed: 10217061
Alzheimers Res Ther. 2010 Oct 22;2(5):30
pubmed: 21067555
J Mol Model. 2018 May 31;24(6):138
pubmed: 29855721
Molecules. 2018 Mar 02;23(3):
pubmed: 29498665
Trends Neurosci. 2002 Jan;25(1):22-6
pubmed: 11801334
Colloids Surf B Biointerfaces. 2020 Jun;190:110948
pubmed: 32160583
Eur J Neurol. 2007 Jan;14(1):e1-26
pubmed: 17222085
J Phys Chem A. 2005 Jan 13;109(1):205-12
pubmed: 16839107
Molecules. 2019 Mar 21;24(6):
pubmed: 30901820
Curr Drug Targets. 2020;21(7):628-646
pubmed: 31744447
ACS Omega. 2019 Jul 23;4(7):12555-12560
pubmed: 31460375
Molecules. 2020 Jun 22;25(12):
pubmed: 32580359
Biol Pharm Bull. 2012;35(2):260-4
pubmed: 22293359
Biochim Biophys Acta. 2015 Aug;1850(8):1642-60
pubmed: 25459512
Int J Psychiatry Med. 2006;36(4):401-12
pubmed: 17407994
Neurology. 2004 Jun 8;62(11):1984-9
pubmed: 15184601
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
J Comput Chem. 1999 May;20(7):720-729
pubmed: 34376030
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
Mar Drugs. 2020 Sep 20;18(9):
pubmed: 32962305
J Neurosci Rural Pract. 2011 Jan;2(1):56-61
pubmed: 21716802
Front Chem. 2021 Jan 27;8:624716
pubmed: 33732682
Curr Alzheimer Res. 2017;14(11):1182-1189
pubmed: 28164767
Molecules. 2020 Sep 11;25(18):
pubmed: 32932850
Nature. 1999 Jun 24;399(6738 Suppl):A23-31
pubmed: 10392577
N Engl J Med. 1995 Nov 9;333(19):1242-7
pubmed: 7566000
J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):137-47
pubmed: 10071091
Dement Neurocogn Disord. 2018 Dec;17(4):131-136
pubmed: 30906402
Recent Pat Drug Deliv Formul. 2012 Apr 1;6(1):2-18
pubmed: 22272933
J Alzheimers Dis Rep. 2020 Oct 24;4(1):417-429
pubmed: 33283163
J Alzheimers Dis. 2011;23(2):249-55
pubmed: 20930268
Mol Neurobiol. 2020 Feb;57(2):926-936
pubmed: 31612296
Curr Neuropharmacol. 2016;14(1):101-15
pubmed: 26813123
Nature. 2009 Feb 19;457(7232):981-9
pubmed: 19225519
Nucleic Acids Res. 2019 Jul 2;47(W1):W357-W364
pubmed: 31106366
J Mol Model. 2012 Sep;18(9):4299-307
pubmed: 22570079
Phys Chem Chem Phys. 2012 Dec 21;14(47):16187-91
pubmed: 23132141
Evid Based Complement Alternat Med. 2021 Jun 25;2021:9995614
pubmed: 34257698
Molecules. 2020 Oct 30;25(21):
pubmed: 33143044
Chem Sci. 2021 Mar 31;12(18):6264-6279
pubmed: 34084424
Phys Chem Chem Phys. 2005 Sep 21;7(18):3297-305
pubmed: 16240044
Arch Neurol. 2008 Mar;65(3):329-34
pubmed: 18332245
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977-81
pubmed: 8446617
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
J Phys Chem B. 2009 May 7;113(18):6378-96
pubmed: 19366259
Phys Chem Chem Phys. 2006 Mar 7;8(9):1057-65
pubmed: 16633586
Molecules. 2016 Jun 09;21(6):
pubmed: 27294896
Chem Rev. 2003 May;103(5):1793-873
pubmed: 12744694
ACS Nano. 2016 Feb 23;10(2):2860-70
pubmed: 26844592
Cold Spring Harb Perspect Med. 2012 Aug 01;2(8):
pubmed: 22908189
J Neurosci. 2007 Jan 24;27(4):796-807
pubmed: 17251419
CNS Neurosci Ther. 2010 Aug;16(4):235-45
pubmed: 20560995
Eur Arch Psychiatry Clin Neurosci. 1999;249(6):288-90
pubmed: 10653284
Front Neurosci. 2018 Jan 30;12:25
pubmed: 29440986
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5644-51
pubmed: 16567625
Angew Chem Int Ed Engl. 2010 Aug 23;49(36):6288-308
pubmed: 20648499
Org Biomol Chem. 2009 Sep 7;7(17):3576-83
pubmed: 19675915
J Mol Model. 2013 Jul;19(7):2715-22
pubmed: 22846923
Molecules. 2021 May 06;26(9):
pubmed: 34066433
Brain. 2009 Aug;132(Pt 8):2048-57
pubmed: 19460794
Neuroimage. 2009 Oct 1;47(4):1196-206
pubmed: 19463961
Prog Neurobiol. 2003 May;70(1):1-32
pubmed: 12927332